论文部分内容阅读
国家经贸委医药司副司长许修雷认为,从全国医药行业的生产、经营情况分析,结构不合理主要表现在品种、企业组织、国内市场的商品销售三个方面: 品种结构:产品雷同太多。据统计,国内目前有上百个品种的生产能力过剩,化学原料药和制剂普遍销售不畅,曾号称我国两大战略品种的VC和青霉素的生产能力利用率也只有50％和70％左右。其他如制剂中的针剂的生产能力利用率仅43.6％,片剂为40.7％、胶囊剂为38.7％、大输液为48.5％、粉针剂为50.5％。
Xu Xiulei, Deputy Director of the Division of Pharmaceuticals of the State Economic and Trade Commission, believes that from the analysis of the production and operation of the national pharmaceutical industry, the irrational structure is mainly reflected in three aspects: variety, enterprise organization, and domestic market sales of goods: Variety structure: There are too many similar products. According to statistics, there are currently hundreds of varieties of excess production capacity, the general sales of chemical raw materials and pharmaceutical preparations are poor, and the utilization rate of VC and penicillin production capacity of two major strategic varieties in China is only about 50% and 70%. Others such as the preparation of the injection capacity utilization rate was only 43.6%, 40.7% for tablets, 38.7% for capsules, 48.5% for large infusions, and 50.5% for powder injections.